The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study.

Share:

Antihypertensives are effective at reducing the risk of cardiovascular disease, but limited data exist quantifying their association with serious adverse events, particularly in older people with frailty. This study aimed to examine this association using nationally representative electronic health record data.

References: Sheppard JP, Koshiaris C, Stevens R, Lay-Flurrie S, Banerjee A, Bellows BK, Clegg A, Hobbs FDR, Payne RA, Swain S, Usher-Smith JA, McManus RJ. The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study. PLoS Medicine 2023;20(4):e1004223. https://doi.org/10.1371/journal.pmed.1004223

Details:

Theme:

Author(s):

Sheppard JP, Koshiaris C, Stevens R, Lay-Flurrie S, Banerjee A, Bellows BK, Clegg A, Hobbs FDR, Payne RA, Swain S, Usher-Smith JA, McManus RJ.

Theme Lead

Related Publications

Using the new electronic frailty index (eFI2) to aid frailty identification and management in primary care

Development and external validation of the electronic frailty index 2 using routine primary care electronic health record data

The association between frailty, care receipt and unmet need for care with the risk of hospital admissions